Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
ProPhase Labs, Inc.

ProPhase Labs, Inc. (PRPH) Stock Overview

Explore ProPhase Labs, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PRPH●NASDAQ
HealthcareMedical - Pharmaceuticals
$0.02
$0.005(17.67%)
U.S. Market opens in 52h 55m

ProPhase Labs, Inc. (PRPH)

Meyka AI Score

Z

Key Financials

Market Cap346.2K
P/E Ratio-0.01
EPS (TTM)$-3.01
ROE-13.59%
Fundamental Analysis

AI Price Forecasts

1 Month$0.10
3 Months$0.03
1 Year Target$0.00

PRPH Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of ProPhase Labs, Inc. (NASDAQ: PRPH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, ProPhase Labs, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PRPH on the NASDAQ shows an RSI of 26.31, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind ProPhase Labs, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.01 and a market capitalization of 346.2K. Combined with our AI analysis, these give both institutional and retail investors a clear view of PRPH on the NASDAQ.

Price Performance (NASDAQ: PRPH)

1-Day Change
-17.67%
5-Day Change
-42.76%
1-Month Change
-64.61%
3-Month Change
-72.56%
6-Month Change
-84.56%
Year-to-Date (YTD) Change
-94.51%
1-Year Change
-99.26%
3-Year Change
-99.91%
5-Year Change
-99.91%
All-Time (Max) Change
-99.90%

Contact Information

https://www.prophaselabs.com
215 345 0919
626 RXR Plaz, Uniondale, NY, 11556

Company Facts

190 Employees
IPO DateApr 4, 1994
CountryUS
Actively Trading

Frequently Asked Questions